Cargando…

Fuzheng Kang-Ai decoction enhances the effect of Gefitinib-induced cell apoptosis in lung cancer through mitochondrial pathway

BACKGROUND: Our previous clinical study has shown that Chinese herbal medicine (CHM) Fuzheng Kang-Ai (FZKA) decoction is effective in treating advanced lung cancer patients through prolonging the drug resistance to Gefitinib (GFTN). Our basic study found that FZKA decoction could enhance the inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Sumei, Peng, Zhiwei, Li, Wenjuan, Long, Shunqin, Xiao, Shujing, Wu, Wanyin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247206/ https://www.ncbi.nlm.nih.gov/pubmed/32489321 http://dx.doi.org/10.1186/s12935-020-01270-3

Ejemplares similares

Decoction of Chinese Herbal Medicine Fuzheng Kang-Ai Induces Lung Cancer Cell Apoptosis via STAT3/Bcl-2/Caspase-3 Pathway
por: Wang, Sumei, et al.
Publicado: (2018)

Traditional Chinese medicine, Fuzheng Kang-Ai decoction, inhibits metastasis of lung cancer cells through the STAT3/MMP9 pathway
por: Li, Longmei, et al.
Publicado: (2017)

Traditional Chinese medicine, Fuzheng Kang-Ai decoction, inhibits metastasis of lung cancer cells through the STAT3/MMP9 pathway
por: Li, Longmei, et al.
Publicado: (2021)

Fuzheng Kang’ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: study protocol for a randomized controlled trial
por: Yang, Xiao-Bing, et al.
Publicado: (2015)

Chinese Herbal Medicine Fuzheng Kang-Ai Decoction Inhibited Lung Cancer Cell Growth through AMPKα-Mediated Induction and Interplay of IGFBP1 and FOXO3a
por: Zheng, Fang, et al.
Publicado: (2016)

GPX4 Plays a Crucial Role in Fuzheng Kang’ai Decoction-Induced Non-Small Cell Lung Cancer Cell Ferroptosis
por: Zhao, Yue-Yang, et al.
Publicado: (2022)

Efficacy and Safety of Fuzheng Yiqi Kang-Ai Decoction Combined with External Irradiation in the Treatment of Undifferentiated Thyroid Carcinoma and Its Influence on Antiangiogenesis
por: Bian, Li, et al.
Publicado: (2022)

Yangyin Fuzheng Decoction enhances anti-tumor efficacy of cisplatin on lung cancer
por: Wei, Dongmei, et al.
Publicado: (2018)

Molecular targets of Yangyin Fuzheng Jiedu Prescription in the treatment of hepatocellular carcinoma based on network pharmacology analysis
por: Yan, Fengna, et al.
Publicado: (2020)

Network Pharmacology Interpretation of Fuzheng–Jiedu Decoction against Colorectal Cancer
por: Shi, Hongshuo, et al.
Publicado: (2021)

Study on metastasis inhibition of Kejinyan decoction on lung cancer by affecting tumor microenvironment
por: Chen, Meijuan, et al.
Publicado: (2020)

MicroRNA-24 in Cancer: A Double Side Medal With Opposite Properties
por: Wang, Sumei, et al.
Publicado: (2020)

Association of integrin beta1 and c-MET in mediating EGFR TKI gefitinib resistance in non-small cell lung cancer
por: Ju, Lixia, et al.
Publicado: (2013)

In Vitro Antibacterial Experiment of Fuzheng Jiedu Huayu Decoction Against Multidrug-Resistant Pseudomonas aeruginosa
por: Xu, Hongri, et al.
Publicado: (2020)

BAD overexpression inhibits cell growth and induces apoptosis via mitochondrial-dependent pathway in non-small cell lung cancer
por: Jiang, Li, et al.
Publicado: (2013)

Protocol for a systematic review and meta-analysis of Kang-ai injection for patients with oesophageal cancer
por: Song, Qingping, et al.
Publicado: (2020)

QnAs with Le Kang
por: Ahmed, Farooq
Publicado: (2023)

KangPiLao decoction modulates cognitive and emotional disorders in rats with central fatigue through the GABA/Glu pathway
por: Xu, Yifei, et al.
Publicado: (2022)

Proliferation of Ewing sarcoma cell lines is suppressed by the receptor tyrosine kinase inhibitors gefitinib and vandetanib
por: Andersson, Mattias K, et al.
Publicado: (2008)

Fuzheng Quxie Decoction Ameliorates Learning and Memory Impairment in SAMP8 Mice by Decreasing Tau Hyperphosphorylation
por: Yang, Yang, et al.
Publicado: (2017)

Apatinib preferentially inhibits PC9 gefitinib-resistant cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway
por: Song, Yong-An, et al.
Publicado: (2019)

MiRNA-125a-5p: a regulator and predictor of gefitinib’s effect on nasopharyngeal carcinoma
por: Liu, Yanyang, et al.
Publicado: (2014)

Synergistic induction of apoptosis by salinomycin and gefitinib through lysosomal and mitochondrial dependent pathway overcomes gefitinib resistance in colorectal cancer
por: Zou, Zheng-Zhi, et al.
Publicado: (2015)

Response to Mahatanan and Kang: It's Complicated
por: Molina, Kyle C, et al.
Publicado: (2023)

Solamargine inhibits the growth of hepatocellular carcinoma and enhances the anticancer effect of sorafenib by regulating HOTTIP‐TUG1/miR‐4726‐5p/MUC1 pathway
por: Tang, Qing, et al.
Publicado: (2022)

A cross-talk between integrin β4 and epidermal growth factor receptor induces gefitinib chemoresistance to gastric cancer
por: Huafeng, Jia, et al.
Publicado: (2018)

The Chinese herbal formula Fuzheng Quxie Decoction attenuates cognitive impairment and protects cerebrovascular function in SAMP8 mice
por: Wang, Feixue, et al.
Publicado: (2018)

Clinical Efficacy of Fuzheng Guben Anticancer Decoction Combined with Taxol in Treating Ovarian Carcinoma and Its Effect on Complication Incidence
por: Li, Pinger, et al.
Publicado: (2021)

Emodin induces apoptosis of human cervical cancer hela cells via intrinsic mitochondrial and extrinsic death receptor pathway
por: Yaoxian, Wang, et al.
Publicado: (2013)

IL-2 augments the sorafenib-induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway
por: Ding, Xiaoyan, et al.
Publicado: (2018)

The Effect of Transarterial Chemoembolization in Combination With Kang’ai Injection on Patients With Intermediate Stage Hepatocellular Carcinoma: A Prospective Study
por: Wan, Yue-Meng, et al.
Publicado: (2017)

Uncovering the mechanism of Kang-ai injection for treating intrahepatic cholangiocarcinoma based on network pharmacology, molecular docking, and in vitro validation
por: Song, Fei, et al.
Publicado: (2023)

The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers
por: Tang, Qing, et al.
Publicado: (2022)

TAZ inhibition promotes IL-2-induced apoptosis of hepatocellular carcinoma cells by activating the JNK/F-actin/mitochondrial fission pathway
por: Ji, Kaihua, et al.
Publicado: (2018)

Deguelin induces the apoptosis of lung cancer cells through regulating a ROS driven Akt pathway
por: Xu, Huae, et al.
Publicado: (2015)

Fuzheng Huayu recipe alleviates hepatic fibrosis via inhibiting TNF-α induced hepatocyte apoptosis
por: Tao, Yan-yan, et al.
Publicado: (2014)

Efficacy and safety of Chinese patent medicine (Kang-ai injection) as an adjuvant in the treatment of patients with hepatocellular carcinoma: a meta-analysis
por: Sun, Chuihua, et al.
Publicado: (2021)

Huanglianjiedu Decoction as an effective treatment for oral squamous cell carcinoma based on network pharmacology and experimental validation
por: Zhang, Lejun, et al.
Publicado: (2021)

Speckle-type POZ protein functions as a tumor suppressor in non-small cell lung cancer due to DNA methylation
por: Yao, Sumei, et al.
Publicado: (2018)

Resveratrol overcomes gefitinib resistance by increasing the intracellular gefitinib concentration and triggering apoptosis, autophagy and senescence in PC9/G NSCLC cells
por: Zhu, Yinsong, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1cf91b7cemegufc6cf32raedv7